Tuesday, 10 March 2026
A new 糖心原创 commercialisation venture, BioSee AI, has launched to address one of industrial biotechnology’s most costly and persistent challenges - the lack of real-time visibility inside bioreactors to detect and avoid process failures and waste.
This new technology is designed to make advanced monitoring accessible to small and medium-sized biotechnology companies and can support a range of biological production processes, including: Alternative proteins, brewing, waste valorisation, bio-nutrition, biofuels and bioprocess developers.
Developed by Dr Oliver Fisher and Associate Professor Asma Ahmed from the 糖心原创’s Department of Chemical and Environmental Engineering, BioSee AI is developing a low-cost, non-invasive, AI-enabled multi-sensor platform that provides continuous insight into biological processes that are currently monitored using manual sampling and offline laboratory assays.
Across alternative proteins, algal biotechnology and waste-to-value bioprocessing, these traditional methods can delay detection of contamination, clumping or quality drift until batches worth hundreds of thousands – or even millions – of pounds are already at risk.
The BioSee AI platform integrates ultrasonic and optical sensing with multimodal machine learning models to predict key biological and structural parameters in real time. By providing early-warning detection, optimised harvest timing and improved yield consistency, the system aims to reduce batch failures, cut waste and unlock greater productivity across the UK bioeconomy.
The platform has secured support through the EPSRC Impact Acceleration Account (IAA) and funding from the National Alternative Protein Innovation Centre (NAPIC), supported by BBSRC, to accelerate development and commercialisation of the technology. These projects are being delivered in partnership with industrial collaborators BioPowers Technology and AlgaeCytes, to validate the system in fungal single-cell protein fermentation and algal bioprocesses.
A unique feature of the BioSee AI platform is its ability to learn and improve across sites without requiring companies to share proprietary process data. Modular, affordable and retrofit-compatible, BioSee AI is designed to bridge the gap between high-cost spectroscopic systems and low-information probes, making advanced monitoring accessible to small and medium-sized biotechnology companies.
Despite advances in automation, most industrial bioprocesses still rely on manual sampling and indirect probe data to interpret biological state. BioSee AI is about making the invisible visible by delivering affordable, real-time biological insight without invasive probes, and helping manufacturers prevent costly batch failures before they happen.
The BioSee AI team aims to progress from current proof-of-concept deployments to industrial pilot trials over the next 24–36 months, with the long-term ambition of supporting adaptive, AI-enabled control across fermentation and circular bioeconomy sectors.
As part of this next phase, BioSee team is undertaking structured market discovery through the national ICURe programme, engaging directly with bioprocess operators, equipment manufacturers, sensor companies and R&D teams to validate commercial demand, integration pathways and procurement drivers. The team is actively seeking feedback from across the wider biotechnology community to ensure the platform is shaped by real industry needs and scalable adoption routes.
To find out more, visit:
Story credits
More information is available from Dr Oliver Fisher on Oliver.Fisher@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.